We are live on
!
Find out more
AP
AlpInvest Partners Portfolio holdings
AUM
$49.7M
1-Year Est. Return
23.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+23.93%
3 Year Est. Return
+97.46%
5 Year Est. Return
+64.29%
10 Year Est. Return
+277.58%
AUM
$79M
AUM Growth
+$25.6M
(+48%)
Cap. Flow
+$23.7M
Cap. Flow
% of AUM
30.04%
Top 10 Holdings %
Top 10 Hldgs %
79.77%
Holding
33
New
10
Increased
5
Reduced
4
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLUE
bluebird bio
BLUE
|
+$5.08M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$4.87M |
| 3 |
HubSpot
HUBS
|
+$4.67M |
| 4 |
Larimar Therapeutics
LRMR
|
+$4.49M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$3.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Criteo
CRTO
|
+$4.28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.96M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$1.49M |
| 4 |
EVER
Everbank Financial Corp
EVER
|
+$1.31M |
| 5 |
NMBL
Nimble Storage, Inc.
NMBL
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.61% |
| 2 | Communication Services | 20.19% |
| 3 | Technology | 15.94% |
| 4 | Financials | 4.32% |
| 5 | Energy | 1.63% |
Similar funds
VCMGDR
SRF
7IH
SAMC
VM
CZI
PEP
OM
AlpInvest Partners's Q2 2015 Portfolio in Review
As of Q2 2015, AlpInvest Partners held 33 positions worth $79M, up 48% from $53.4M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
AlpInvest Partners deployed $23.7M of net new capital in Q2 2015, opening 10 new positions and adding to 5 existing holdings. Its largest new stake was bluebird bio: 2,492 shares worth $5.44M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 9.7% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.96M trimmed.
- AlpInvest Partners's largest Q2 2015 buy was bluebird bio: 2,492 shares worth $5.44M.
- AlpInvest Partners added most to IVERIC bio, Inc. Common Stock in Q2 2015, an estimated $3.68M increase.
- AlpInvest Partners's biggest Q2 2015 reduction was Meta Platforms (Facebook), cutting an estimated $1.96M.
- AlpInvest Partners fully exited Criteo in Q2 2015, selling an estimated $4.28M.
- AlpInvest Partners's ten largest holdings make up 80% of its $79M portfolio in Q2 2015.
- AlpInvest Partners opened 10 new positions and closed 9 in Q2 2015.
- AlpInvest Partners's portfolio value rose 48% quarter-over-quarter to $79M.
Based on AlpInvest Partners's 13F filing for Q2 2015, filed 14 Aug 2015.